Form 144 - Report of proposed sale of securities:
SEC Accession No. 0000950170-23-052722
Filing Date
2023-10-10
Accepted
2023-10-10 17:47:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4641
  Complete submission text file 0000950170-23-052722.txt   6212
Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Subject) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-34207 | Film No.: 231318960
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 CLARENDON STREET BOSTON MA 02116
Business Address 200 CLARENDON STREET BOSTON MA 02116 6175162878
BCIP Life Sciences Associates, LP (Reporting) CIK: 0001702921 (see all company filings)

EIN.: 814329455 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144